FGF23 and autosomal dominant hypophosphatemic rickets: Similarly, oral iron supplementation in ADHR patients reduced the high FGF-23 levels [127], whereas certain IV iron preparations, such as those with carboxymaltose backbones, increased iFGF-23 levels [128].